目的进一步完善中国药典中药材质量标准,让学界和业界了解中国药典中药材基原修订的基本思路和目前尚需修订的品种状况,同时为中国药典2030年版中药材基原修订提供参考。方法对中国药典2025年版收载的植物类中药材基原的科、属、种名称...目的进一步完善中国药典中药材质量标准,让学界和业界了解中国药典中药材基原修订的基本思路和目前尚需修订的品种状况,同时为中国药典2030年版中药材基原修订提供参考。方法对中国药典2025年版收载的植物类中药材基原的科、属、种名称与《中国植物志》和Flora of China等植物分类学著作及文献进行查询和考证,并对中国药典2010年版以来中药材基原修订内容及其依据进行剖析,并就学界和业界关注的有关中药材基原问题进行探讨。结果中国药典收载的部分植物基原的中文名称和拉丁学名与植物分类权威著作存在差别,个别甚至存在错误,中国药典2010年版以来对中药材基原的修订是合理的,但尚存在其他问题待修订。结论中国药典中药材基原仍需修订,本文提出了具体问题的修订建议。展开更多
Leveraging unique resource advantages of traditional Chinese medicine(TCM)to achieve innovative breakthroughs in research constitutes a core strategic imperative for its inheritance,innovation and development.At prese...Leveraging unique resource advantages of traditional Chinese medicine(TCM)to achieve innovative breakthroughs in research constitutes a core strategic imperative for its inheritance,innovation and development.At present,the academic advances and scientific achievements in TCM serve as a key driving force for industry growth and advancement of the inheritance and innovation of TCM.To continuously strengthen the leading role of academic research,the China Association of Chinese Medicine(CACM)attaches great importance to the latest research directions and academic results in TCM,and spotlights key advances and emerging trends in TCM scholarship.Since 2020,CACM has conducted the selection and release of the“top 10 academic advances in traditional Chinese medicine”on a yearly basis.The selection of“top 10 academic advances in traditional Chinese medicine in 2024”prioritized research that addresses clinical needs,answers scientific questions and drives industrial development.Highlighting exploratory,forward-looking,innovative and groundbreaking achievements,the following 10 breakthroughs were selected through a process of collection,systematic review and expert evaluation:New advances in prevention and treatment of digestive system diseases with“brain-gut”cross-organ strategy,high-level evidence support for prevention and treatment of cardiovascular disease(CVD)continuum with TCM,important breakthrough in the research on prevention and treatment of acute radiation injury with TCM,elucidation of molecular mechanisms underlying“excellent shape and high quality”variation in cultivated American ginseng through domestication,biosynthesis of trace active ingredients such as benzylisoquinoline alkaloids,pilot application of artificial intelligence(AI)technology,research technology for unelucidated constituents of TCM,new drug delivery system in TCM,and establishment and preliminary application of integrated evidence chain-based effectiveness evaluation of TCM(iEC-Eff).展开更多
文摘目的进一步完善中国药典中药材质量标准,让学界和业界了解中国药典中药材基原修订的基本思路和目前尚需修订的品种状况,同时为中国药典2030年版中药材基原修订提供参考。方法对中国药典2025年版收载的植物类中药材基原的科、属、种名称与《中国植物志》和Flora of China等植物分类学著作及文献进行查询和考证,并对中国药典2010年版以来中药材基原修订内容及其依据进行剖析,并就学界和业界关注的有关中药材基原问题进行探讨。结果中国药典收载的部分植物基原的中文名称和拉丁学名与植物分类权威著作存在差别,个别甚至存在错误,中国药典2010年版以来对中药材基原的修订是合理的,但尚存在其他问题待修订。结论中国药典中药材基原仍需修订,本文提出了具体问题的修订建议。
基金supported by the Project of Map of Scientific and Technological Talents in the Field of Traditional Chinese Medicine(No.XMSB20240923106).
文摘Leveraging unique resource advantages of traditional Chinese medicine(TCM)to achieve innovative breakthroughs in research constitutes a core strategic imperative for its inheritance,innovation and development.At present,the academic advances and scientific achievements in TCM serve as a key driving force for industry growth and advancement of the inheritance and innovation of TCM.To continuously strengthen the leading role of academic research,the China Association of Chinese Medicine(CACM)attaches great importance to the latest research directions and academic results in TCM,and spotlights key advances and emerging trends in TCM scholarship.Since 2020,CACM has conducted the selection and release of the“top 10 academic advances in traditional Chinese medicine”on a yearly basis.The selection of“top 10 academic advances in traditional Chinese medicine in 2024”prioritized research that addresses clinical needs,answers scientific questions and drives industrial development.Highlighting exploratory,forward-looking,innovative and groundbreaking achievements,the following 10 breakthroughs were selected through a process of collection,systematic review and expert evaluation:New advances in prevention and treatment of digestive system diseases with“brain-gut”cross-organ strategy,high-level evidence support for prevention and treatment of cardiovascular disease(CVD)continuum with TCM,important breakthrough in the research on prevention and treatment of acute radiation injury with TCM,elucidation of molecular mechanisms underlying“excellent shape and high quality”variation in cultivated American ginseng through domestication,biosynthesis of trace active ingredients such as benzylisoquinoline alkaloids,pilot application of artificial intelligence(AI)technology,research technology for unelucidated constituents of TCM,new drug delivery system in TCM,and establishment and preliminary application of integrated evidence chain-based effectiveness evaluation of TCM(iEC-Eff).
